Skip to content

Drug interactions

Talquetamab + Warfarin

Severity: Moderate

Talquetamab and Warfarin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Talquetamab causes cytokine release, which can transiently suppress CYP enzyme activity. This may raise exposure to warfarin and increase the INR, with bleeding risk. The risk is highest during step-up dosing and around cytokine release syndrome episodes.

What this interaction means in plain words

Talquetamab and Warfarin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Talquetamab belongs to Oncology; Warfarin belongs to Cardiovascular.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP enzymes (including CYP2C9) reduces warfarin clearance.

What to do

Monitor INR more frequently during step-up dosing and for about two weeks after the first treatment dose, and during any cytokine release syndrome. Adjust the warfarin dose as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Talquetamab and Warfarin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Talquetamab with Warfarin?

MediHelp rates the interaction as moderate. Talquetamab and Warfarin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Talquetamab causes cytokine release, which can transiently suppress CYP enzyme activity. This may raise exposure to warfarin and increase the INR, with bleeding risk. The risk is highest during step-up dosing and around cytokine release syndrome episodes.

How serious is the interaction between Talquetamab and Warfarin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor INR more frequently during step-up dosing and for about two weeks after the first treatment dose, and during any cytokine release syndrome. Adjust the warfarin dose as needed.

What other medicines interact with Warfarin?

MediHelp also lists interactions of Warfarin with, for example, Defibrotide, Ketorolac, Abciximab. The full list is on the Warfarin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in